Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone

Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone

<p>Abstract</p> <p>Background</p> <p>The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) is a randomized, double-blind, active-controlled trial designed to compare the rate of coronary heart disease events in high-risk hypertensive p...

Full description

Bibliographic Details
Main Authors: Leenen Frans HH, Williamson Jeff D, Wright Jackson T, Cushman William C, Cutler Jeffrey A, Davis Barry R, Piller Linda B, Einhorn Paula T, Randall Otelio S, Golden John S, Haywood L Julian
Format: Article
Language:English
Published: BMC 2002-11-01
Series:Current Controlled Trials in Cardiovascular Medicine
Subjects:
heart failure
alpha-blocker
diuretic
clinical trial
Online Access:http://cvm.controlled-trials.com/content/3/1/10

Internet

http://cvm.controlled-trials.com/content/3/1/10

Similar Items